000 01659 a2200493 4500
005 20250513074638.0
264 0 _c19930415
008 199304s 0 0 eng d
022 _a0003-4975
024 7 _a10.1016/0003-4975(93)90264-i
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGillinov, A M
245 0 0 _aComplement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass.
_h[electronic resource]
260 _bThe Annals of thoracic surgery
_cMar 1993
300 _a619-24 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aCardiopulmonary Bypass
_xadverse effects
650 0 4 _aComplement Activation
650 0 4 _aComplement C3
_xanalysis
650 0 4 _aComplement C5
_xanalysis
650 0 4 _aComplement Hemolytic Activity Assay
650 0 4 _aIn Vitro Techniques
650 0 4 _aLeukocyte Count
650 0 4 _aLung
_xenzymology
650 0 4 _aNeutrophils
_xpathology
650 0 4 _aPeroxidase
_xanalysis
650 0 4 _aPulmonary Circulation
650 0 4 _aReceptors, Complement
_xmetabolism
650 0 4 _aReperfusion Injury
_xpathology
650 0 4 _aSwine
650 0 4 _aVascular Resistance
700 1 _aDeValeria, P A
700 1 _aWinkelstein, J A
700 1 _aWilson, I
700 1 _aCurtis, W E
700 1 _aShaw, D
700 1 _aYeh, C G
700 1 _aRudolph, A R
700 1 _aBaumgartner, W A
700 1 _aHerskowitz, A
773 0 _tThe Annals of thoracic surgery
_gvol. 55
_gno. 3
_gp. 619-24
856 4 0 _uhttps://doi.org/10.1016/0003-4975(93)90264-i
_zAvailable from publisher's website
999 _c8383226
_d8383226